Canlyniadau Chwilio - Caroline Rousseau

Mireinio'r Canlyniadau
  1. 1
    Pretargeting for imaging and therapy in oncological nuclear medicine

    Pretargeting for imaging and therapy in oncological nuclear medicine gan Clément Bailly, Caroline Bodet‐Milin, Caroline Rousseau, Alain Faivre-Chauvet, Françoise Kraeber‐Bodéré, Jacques Barbet

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Focus on the Controversial Aspects of 64Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging

    Focus on the Controversial Aspects of 64Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging gan Mathilde Colombié, Sébastien Gouard, Mathieu Frindel, A. Vidal, Michel Chérel, Françoise Kraeber‐Bodéré, Caroline Rousseau, Mickaël Bourgeois

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Oxalic acid excretion after intravenous ascorbic acid administration

    Oxalic acid excretion after intravenous ascorbic acid administration gan Line Robitaille, Orval Mamer, Wilson H. Miller, Mark Levine, Sarit Assouline, David Melnychuk, Caroline Rousseau, L. John Hoffer

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Phase I clinical trial of i.v. ascorbic acid in advanced malignancy

    Phase I clinical trial of i.v. ascorbic acid in advanced malignancy gan L. John Hoffer, Mark Levine, Sarit Assouline, David Melnychuk, Sebastian J. Padayatty, Kristopher A. Rosadiuk, Caroline Rousseau, Line Robitaille, Wilson H. Miller

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT

    Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT gan Thomas Carlier, Thomas Eugène, Caroline Bodet‐Milin, Étienne Garin, C. Ansquer, Caroline Rousseau, Ludovic Ferrer, Jacques Barbet, Frédéric Schoenahl, Françoise Kraeber‐Bodéré

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    A transfer learning approach to facilitate ComBat-based harmonization of multicentre radiomic features in new datasets

    A transfer learning approach to facilitate ComBat-based harmonization of multicentre radiomic features in new datasets gan Ronrick Da‐ano, François Lucia, Ingrid Masson, Ronan Abgral, Joanne Alfieri, Caroline Rousseau, A. Mervoyer, Caroline Reinhold, Olivier Pradier, Ulrike Schick, Dimitris Visvikis, Mathieu Hatt

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

    Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin gan Sarit Assouline, Biljana Čuljković, Eftihia Cocolakis, Caroline Rousseau, Nathalie Beslu, Abdellatif Amri, Stephen Caplan, Brian Leber, Denis‐Claude Roy, Wilson H. Miller, Katherine L. B. Borden

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

    Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors gan Caroline Rousseau, A. Ruellan, Karine Bernardeau, Françoise Kraeber‐Bodéré, Sébastien Gouard, Delphine Loussouarn, Catherine Saï-Maurel, Alain Faivre-Chauvet, John Wijdenes, Jacques Barbet, Joëlle Gaschet, Michel Chérel, François Davodeau

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Tumor Immunotargeting Using Innovative Radionuclides

    Tumor Immunotargeting Using Innovative Radionuclides gan Françoise Kraeber‐Bodéré, Caroline Rousseau, Caroline Bodet‐Milin, Cédric Mathieu, François Guérard, Éric Frampas, Thomas Carlier, Nicolas Chouin, Férid Haddad, Jean‐François Chatal, Alain Faivre-Chauvet, Michel Chérel, Jacques Barbet

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Potential for Nuclear Medicine Therapy for Glioblastoma Treatment

    Potential for Nuclear Medicine Therapy for Glioblastoma Treatment gan Clément Bailly, Aurélien Vidal, Coralie Bonnemaire, Françoise Kraeber‐Bodéré, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacœuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet‐Milin, Mickaël Bourgeois

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    A pretargeting system for tumor PET imaging and radioimmunotherapy

    A pretargeting system for tumor PET imaging and radioimmunotherapy gan Françoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet‐Milin, Éric Frampas, Alain Faivre-Chauvet, Aurore Rauscher, Robert M. Sharkey, David M. Goldenberg, Jean-François Chatal, Jacques Barbet

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer

    Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer gan Filippa Pettersson, Christina Yau, Monica C. Dobocan, Biljana Culjkovic‐Kraljacic, Hélène Retrouvay, Rachel Puckett, Ludmila M. Flores, Ian E. Krop, Caroline Rousseau, Eftihia Cocolakis, Katherine L. B. Borden, Christopher C. Benz, Wilson H. Miller

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies

    Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies gan Ronrick Da‐ano, Ingrid Masson, François Lucia, M. Doré, Philippe Robin, Joanne Alfieri, Caroline Rousseau, A. Mervoyer, Caroline Reinhold, J. Castelli, R. de Crevoisier, Jean‐François Ramée, Olivier Pradier, Ulrike Schick, Dimitris Visvikis, Mathieu Hatt

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation

    [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation gan Marta S. Ferreira, Pierre Lovinfosse, Johanne Hermesse, Marjolein Decuypere, Caroline Rousseau, François Lucia, Ulrike Schick, Caroline Reinhold, Philippe Robin, Mathieu Hatt, Dimitris Visvikis, Claire Bernard, Ralph T. H. Leijenaar, Frédéric Kridelka, Philippe Lambin, Patrick Meyer, Roland Hustinx

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy

    Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Tre... gan A. Oudoux, Pierre‐Yves Salaün, Claire Bournaud, L. Campion, C. Ansquer, Caroline Rousseau, Stéphane Bardet, Françoise Borson‐Chazot, Jean‐Philippe Vuillez, Arnaud Murat, Éric Mirallié, Jacques Barbet, David M. Goldenberg, Jean‐François Chatal, Françoise Kraeber‐Bodéré

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography

    Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography gan Caroline Rousseau, Anne Devillers, Christine Sagan, Ludovic Ferrer, B. Bridji, L. Campion, Myriam Ricaud, Emmanuelle Bourbouloux, Isabelle Doutriaux, Martine Clouet, Dominique Berton-Rigaud, C. Bouriel, Valérie Delecroix, Étienne Garin, S. Rouquette, I. Resche, Pierre Kerbrat, J. F. Chatal, Mario Campone

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer

    Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer gan François Lucia, Vincent Bourbonne, Clémence Pleyers, Pierre‐François Dupré, O. Miranda, Dimitris Visvikis, Olivier Pradier, Ronan Abgral, A. Mervoyer, Jean-Marc Classe, Caroline Rousseau, Wim Vos, Johanne Hermesse, Christine Gennigens, Marjolein De Cuypere, Frédéric Kridelka, Ulrike Schick, Mathieu Hatt, Roland Hustinx, Pierre Lovinfosse

    Cyhoeddwyd 2023
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

    Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia gan Guillermo Garcia‐Manero, Sarit Assouline, Jorge E. Cortés, Zeev Estrov, Hagop M. Kantarjian, Hui Yang, Willie Newsome, Wilson H. Miller, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, T. Patterson, Zuomei Li, Jeffrey M. Besterman, Gregory K. Reid, Eric Laille, Robert E. Martell, Mark D. Minden

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

    Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement gan Pierre‐Yves Salaün, L. Campion, Claire Bournaud, Alain Faivre-Chauvet, Jean‐Philippe Vuillez, David Taïeb, C. Ansquer, Caroline Rousseau, Françoise Borson‐Chazot, Stéphane Bardet, A. Oudoux, Bertrand Cariou, Éric Mirallié, Chien‐Hsing Chang, Robert M. Sharkey, David M. Goldenberg, Jean‐François Chatal, Jacques Barbet, Françoise Kraeber‐Bodéré

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

    Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma gan Sarit Assouline, Torsten Holm Nielsen, Stephen Yu, Miguel Alcaide, Lauren C. Chong, D. Blair Macdonald, Axel Tosikyan, Vishal Kukreti, Abbas Kezouh, Tina Petrogiannis‐Haliotis, Marco Albuquerque, Daniel Fornika, Sepideh Alamouti, Rémi Froment, Celia M.T. Greenwood, Kathleen Klein Oros, Errol Camglioglu, Ayushi Sharma, Rosa Christodoulopoulos, Caroline Rousseau, Nathalie A. Johnson, Michael Crump, Ryan D. Morin, Koren K. Mann

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: